Contains Milk and Soy
FDA GLP-1 Safety Announcement: Zepbound FDA Safety Label Change and Revised Drug LabelThe revised drug label contains a complete list of FDA-approved indications, side effects, warnings, and more
The American Journal of Clinical Nutrition, 70(5), 928-936
In the median follow up of 3.8 years, the primary outcome occurred in 13% of the patients randomized to liraglutide and approximately 15% of those receiving placebo ( p = 0.01 for superiority [15]
However, if a vial shows cloudiness, discoloration, visible particles, or crystallization, it should never be usedthese signs indicate molecular breakdown or contamination
Changes in low-density lipoprotein cholesterol were comparable to those observed with orlistat, whose mode of action includes reduced dietary fat absorption